FMT holds potential for treating various diseases beyond C. difficile infection, but its regulation by the FDA is crucial due to concerns about long-term effects and unintentional disease transfer.
Keep Reading
Add A Comment
Trending
- Why Advanced IBD Therapies Fail (GI & Endoscopy News)
- AI in prior authorization: the new gatekeeper (KevinMD)
- Physicians finally got a Medicare raise. Keeping it is the hard part. (Medical Economics)
- Arkansas lab pays $30M to settle kickback allegations tied to gastroenterology practices (Becker’s GI & Endoscopy)
- Fluorescent nanosensor enables rapid, first-of-its-kind detection of key gut health biomarker (MIT News)
- Text Messaging and FIT Completion in a Quality Improvement Trial (ReachMD)
- Combined GI Procedures Are Becoming Routine – AI Can Help Address the Gap in Upper GI Quality Standards (MedCity News)
- Endoscopic Robotics Company Channel Robotics Raises $4.6 Million (PR Newswire)
